Participants 0 12 0 12 O
must 13 17 13 17 O
have 18 22 18 22 O
an 23 25 23 25 O
ejection 26 34 26 34 O
fraction 35 43 35 43 O
by 44 46 44 46 O
ECHO 47 51 47 51 B-clinical_variable
or 52 54 52 54 O
MUGA 55 59 55 59 B-clinical_variable
scan 60 64 60 64 I-clinical_variable
≥ 65 66 65 66 O
45 67 69 67 69 B-lower_bound
% 69 70 69 70 I-lower_bound

Participants 0 12 71 83 O
must 13 17 84 88 O
have 18 22 89 93 O
high 23 27 94 98 O
- 27 28 98 99 O
risk 28 32 99 103 O
disease 33 40 104 111 O
, 40 41 111 112 O
as 42 44 113 115 O
defined 45 52 116 123 O
by 53 55 124 126 O
GEP70 56 61 127 132 B-clinical_variable
risk 62 66 133 137 I-clinical_variable
score 67 72 138 143 I-clinical_variable
of 73 75 144 146 O
≥ 76 77 147 148 O
0.66 78 82 149 153 B-lower_bound

Participants 0 12 154 166 O
must 13 17 167 171 O
have 18 22 172 176 O
preserved 23 32 177 186 O
renal 33 38 187 192 O
function 39 47 193 201 O
as 48 50 202 204 O
defined 51 58 205 212 O
by 59 61 213 215 O
a 62 63 216 217 O
serum 64 69 218 223 B-clinical_variable
creatinine 70 80 224 234 I-clinical_variable
level 81 86 235 240 I-clinical_variable
of 87 89 241 243 O
< 90 91 244 245 O
3 92 93 246 247 B-upper_bound
mg 94 96 248 250 I-upper_bound
/ 96 97 250 251 I-upper_bound
dL 97 99 251 253 I-upper_bound

Patients 0 8 254 262 O
must 9 13 263 267 O
be 14 16 268 270 O
at 17 19 271 273 O
least 20 25 274 279 O
18 26 28 280 282 B-lower_bound
years 29 34 283 288 I-lower_bound
of 35 37 289 291 O
age 38 41 292 295 B-age
and 42 45 296 299 O
not 46 49 300 303 O
older 50 55 304 309 O
than 56 60 310 314 O
75 61 63 315 317 B-upper_bound
years 64 69 318 323 I-upper_bound
of 70 72 324 326 O
age 73 76 327 330 O
at 77 79 331 333 O
the 80 83 334 337 O
time 84 88 338 342 O
of 89 91 343 345 O
registration 92 104 346 358 O

Patients 0 8 359 367 O
must 9 13 368 372 O
be 14 16 373 375 O
either 17 23 376 382 O
untreated 24 33 383 392 O
or 34 36 393 395 O
have 37 41 396 400 O
not 42 45 401 404 O
had 46 49 405 408 O
more 50 54 409 413 O
than 55 59 414 418 O
one 60 63 419 422 O
cycle 64 69 423 428 O
of 70 72 429 431 O
systemic 73 81 432 440 B-treatment
MM 82 84 441 443 I-treatment
therapy 85 92 444 451 I-treatment

Patients 0 8 452 460 O
must 9 13 461 465 O
have 14 18 466 470 O
a 19 20 471 472 O
platelet 21 29 473 481 B-clinical_variable
count 30 35 482 487 I-clinical_variable
of 36 38 488 490 O
≥ 39 40 491 492 O
50,000 41 47 493 499 B-lower_bound
/ 47 48 499 500 I-lower_bound
μL 48 50 500 502 I-lower_bound

Patients 0 8 503 511 O
must 9 13 512 516 O
have 14 18 517 521 O
adequate 19 27 522 530 B-clinical_variable
pulmonary 28 37 531 540 I-clinical_variable
function 38 46 541 549 I-clinical_variable
studies 47 54 550 557 I-clinical_variable
> 55 56 558 559 O
50 57 59 560 562 B-lower_bound
% 59 60 562 563 I-lower_bound
of 61 63 564 566 O
predicted 64 73 567 576 O
on 74 76 577 579 O
mechanical 77 87 580 590 O
aspects 88 95 591 598 O
( 96 97 599 600 O
FEV1 97 101 600 604 B-clinical_variable
, 101 102 604 605 O
FVC 103 106 606 609 B-clinical_variable
, 106 107 609 610 O
etc 108 111 611 614 O
) 111 112 614 615 O
and 113 116 616 619 O
diffusion 117 126 620 629 B-clinical_variable
capacity 127 135 630 638 I-clinical_variable
( 136 137 639 640 I-clinical_variable
DLCO 137 141 640 644 I-clinical_variable
) 141 142 644 645 I-clinical_variable
> 143 144 646 647 O
50 145 147 648 650 O
% 147 148 650 651 O
of 149 151 652 654 O
predicted 152 161 655 664 O

Patients 0 8 665 673 O
must 9 13 674 678 O
have 14 18 679 683 O
newly 19 24 684 689 O
diagnosed 25 34 690 699 O
active 35 41 700 706 O
MM 42 44 707 709 B-cancer
requiring 45 54 710 719 O
treatment 55 64 720 729 B-treatment

Patients 0 8 730 738 O
must 9 13 739 743 O
have 14 18 744 748 O
signed 19 25 749 755 O
an 26 28 756 758 O
IRB 29 32 759 762 O
- 32 33 762 763 O
approved 33 41 763 771 O
informed 42 50 772 780 O
consent 51 58 781 788 O
indicating 59 69 789 799 O
their 70 75 800 805 O
understanding 76 89 806 819 O
of 90 92 820 822 O
the 93 96 823 826 O
proposed 97 105 827 835 O
treatment 106 115 836 845 B-treatment
and 116 119 846 849 O
understanding 120 133 850 863 O
that 134 138 864 868 O
the 139 142 869 872 O
protocol 143 151 873 881 O
has 152 155 882 885 O
been 156 160 886 890 O
approved 161 169 891 899 O
by 170 172 900 902 O
the 173 176 903 906 O
IRB 177 180 907 910 O

Patients 0 8 911 919 O
must 9 13 920 924 O
not 14 17 925 928 O
have 18 22 929 933 O
prior 23 28 934 939 O
malignancy 29 39 940 950 B-cancer

Poorly 0 6 951 957 O
controlled 7 17 958 968 O
hypertension 18 30 969 981 B-chronic_disease
, 30 31 981 982 O
diabetes 32 40 983 991 B-chronic_disease
mellitus 41 49 992 1000 I-chronic_disease
, 49 50 1000 1001 O
or 51 53 1002 1004 O
other 54 59 1005 1010 O
serious 60 67 1011 1018 O
medical 68 75 1019 1026 O
illness 76 83 1027 1034 O
or 84 86 1035 1037 O
psychiatric 87 98 1038 1049 B-chronic_disease
illness 99 106 1050 1057 I-chronic_disease
that 107 111 1058 1062 O
could 112 117 1063 1068 O
potentially 118 129 1069 1080 O
interfere 130 139 1081 1090 O
with 140 144 1091 1095 O
the 145 148 1096 1099 O
completion 149 159 1100 1110 O
of 160 162 1111 1113 O
treatment 163 172 1114 1123 B-treatment
according 173 182 1124 1133 O
to 183 185 1134 1136 O
this 186 190 1137 1141 O
protocol 191 199 1142 1150 O

Pregnant 0 8 1151 1159 B-pregnancy

Subjects 0 8 1160 1168 O
of 9 11 1169 1171 O
reproductive 12 24 1172 1184 O
potential 25 34 1185 1194 O
may 35 38 1195 1198 O
not 39 42 1199 1202 O
participate 43 54 1203 1214 O
unless 55 61 1215 1221 O
they 62 66 1222 1226 O
have 67 71 1227 1231 O
agreed 72 78 1232 1238 B-contraception_consent
to 79 81 1239 1241 I-contraception_consent
use 82 85 1242 1245 I-contraception_consent
an 86 88 1246 1248 I-contraception_consent
effective 89 98 1249 1258 I-contraception_consent
contraceptive 99 112 1259 1272 I-contraception_consent
method 113 119 1273 1279 I-contraception_consent

Women 0 5 1280 1285 B-gender
of 6 8 1286 1288 O
childbearing 9 21 1289 1301 O
potential 22 31 1302 1311 O
must 32 36 1312 1316 B-pregnancy
have 37 41 1317 1321 I-pregnancy
a 42 43 1322 1323 I-pregnancy
negative 44 52 1324 1332 I-pregnancy
pregnancy 53 62 1333 1342 I-pregnancy
documented 63 73 1343 1353 O
within 74 80 1354 1360 O
one 81 84 1361 1364 B-upper_bound
week 85 89 1365 1369 I-upper_bound
of 90 92 1370 1372 O
registration 93 105 1373 1385 O

Zubrod 0 6 1386 1392 B-clinical_variable
≤ 7 8 1393 1394 O
2 9 10 1395 1396 B-upper_bound

adequately 0 10 1397 1407 O
treated 11 18 1408 1415 O
basal 19 24 1416 1421 B-cancer
cell 25 29 1422 1426 I-cancer
or 30 32 1427 1429 O
squamous 33 41 1430 1438 B-cancer
cell 42 46 1439 1443 I-cancer
skin 47 51 1444 1448 I-cancer
cancer 52 58 1449 1455 I-cancer

bisphosphonates 0 15 1456 1471 B-treatment

in 0 2 1472 1474 O
situ 3 7 1475 1479 B-cancer
cervical 8 16 1480 1488 I-cancer
cancer 17 23 1489 1495 I-cancer

localized 0 9 1496 1505 O
radiation 10 19 1506 1515 B-treatment

lower 0 5 1516 1521 O
levels 6 12 1522 1528 O
are 13 16 1529 1532 O
explained 17 26 1533 1542 O
by 27 29 1543 1545 O
extensive 30 39 1546 1555 O
bone 40 44 1556 1560 O
marrow 45 51 1561 1567 O
plasmacytosis 52 65 1568 1581 B-chronic_disease

nursing 0 7 1582 1589 O
women 8 13 1590 1595 B-gender
may 14 17 1596 1599 O
not 18 21 1600 1603 O
participate 22 33 1604 1615 O

other 0 5 1616 1621 O
cancer 6 12 1622 1628 B-cancer
for 13 16 1629 1632 O
which 17 22 1633 1638 O
the 23 26 1639 1642 O
patient 27 34 1643 1650 O
has 35 38 1651 1654 O
not 39 42 1655 1658 O
received 43 51 1659 1667 O
treatment 52 61 1668 1677 B-treatment
for 62 65 1678 1681 O
one 66 69 1682 1685 B-upper_bound
year 70 74 1686 1690 I-upper_bound
prior 75 80 1691 1696 I-upper_bound
to 81 83 1697 1699 O
enrollment 84 94 1700 1710 O

solely 0 6 1711 1717 O
due 7 10 1718 1721 O
to 11 13 1722 1724 O
symptoms 14 22 1725 1733 O
of 23 25 1734 1736 O
MM 26 28 1737 1739 B-cancer
- 28 29 1739 1740 O
related 29 36 1740 1747 O
bone 37 41 1748 1752 B-chronic_disease
disease 42 49 1753 1760 I-chronic_disease

